Physician profile
Jon C Driscoll
NPI 1386667574
$988.89
in general payments reported to CMS, 2019-2025
12 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2021: $36.02 · 2022: $40.37 · 2023: $72.24 · 2024: $117 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $503.57 | 2022-2025 | Real Intelligence, Spatial Frame, Na |
| Pacira Therapeutics, INC. | $183.40 | 2019-2021 | |
| Stryker Corporation | $76.91 | 2019-2024 | Ortholoc 3di |
| Vericel Corporation | $63.15 | 2025 | Maci |
| Depuy Synthes Sales INC. | $28.49 | 2019 | |
| Djo, LLC | $24.09 | 2019 | |
| Nevro Corp. | $20.17 | 2019 | |
| Si-Bone, INC. | $19.81 | 2025 | |
| Orthofix Medical, INC. | $19.54 | 2023 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $19.17 | 2019 | |
| Zimvie INC. | $16.58 | 2022 | |
| Bioventus LLC | $14.01 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Driscoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.